Akers Biosciences Announces A Leadership Change Strategic Update Legal Settlement And An Aim Update | Latest News RSS feed

Akers Biosciences Announces A Leadership Change Strategic Update Legal Settlement And An Aim Update - Latest News


Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

Howard R. Yeaton has been appointed to the position of Chief Executive Officer effective immediately. Mr. Yeaton’s role of Chief Executive Officer is not a board position although he will work very ... read more

Akers Biosciences Announces Q3 2018 Earnings

THOROFARE, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (AKER ... $104,094), on account of our settlement with Pulse, and a decline in the sales of Breath Alcohol products Q3 gross ... read more

Akers Biosciences Announces Q2 and H1 2018 Earnings

Akers Biosciences, Inc. AKER, +3.08% (aim:AKR.L), ("Akers Bio" or the "Company"), a developer ... our Tri-Cholesterol assay being sold under the "First Check" brand. The leadership team remains ... read more

Looking for another news?


Akers Biosciences Inc (AKER.A)

March 26 (Reuters) - Akers Biosciences Inc ::‍DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO .‍ENTERED INTO 3-YEAR DISTRIBUTION AGREEMENT WITH DIAGNOSTICA STAGO FOR SALE OF CO'S RAPID TEST FOR ... read more


Further Re. Notice of AGM

Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the ... that are subject to change based on various factors (many of which are beyond the Company's control). The Company undertakes no obligation ... read more

Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings

THOROFARE, N.J, March 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will hold ... read more

Akers Biosciences Announces Q3 2018 Earnings

Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” ... read more

Akers Biosciences announces a leadership change and a strategic update

Akers Biosciences (NASDAQ:AKER) announces a leadership change, an update to the Company’s business strategy, the settlement of its lawsuit with Pulse Health LLC and the resignation of its Nominated ... read more

Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

Akers Biosciences, Inc. AKER, +1.06% (aim:AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces a leadership change, an update to the Company's ... read more

Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us